MedTrace Logo

Vitamin D and the Health of Blood Vessels in Kidney Disease

NCT01247311 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 129

Last updated 2017-06-15

No results posted yet for this study

Summary

Individuals with kidney disease have a high risk of heart disease. This is not related to traditional risk factors, such as high blood pressure, high cholesterol or being overweight. A lack of vitamin D could be the reason why blood vessels become damaged and could explain the link between heart disease and kidney disease.

Conditions

  • Chronic Kidney Disease (CKD)

Interventions

DIETARY_SUPPLEMENT

Dietary supplement

Placebo given orally 3xweek for six months

DIETARY_SUPPLEMENT

Vitamin D

5000 IU vitamin D given orally 3xweek for six months

DIETARY_SUPPLEMENT

Vitamin D

0.5ug 1,25 vitamin D given orally 3xweek for six months

Sponsors & Collaborators

  • The Kidney Foundation of Canada

    collaborator OTHER

  • Pfizer

    collaborator INDUSTRY

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Adeera Levin, Dr. · University of British Columbia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-11-30
Primary Completion
2014-08-31
Completion
2014-08-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01247311 on ClinicalTrials.gov